Guangdong Transtek Medical Electronics Co., Ltd (300562.SZ)
CNY 16.27
(-6.92%)
CNY 16.27
(-6.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 884.25 Million | 1.06 Billion | 1.82 Billion | 1.33 Billion | 883.66 Million | 775.1 Million |
| Cost of Revenue | 610.68 Million | 812.71 Million | 1.48 Billion | 1 Billion | 669.16 Million | 574.23 Million |
| Gross Profit | 273.56 Million | 252.38 Million | 337.7 Million | 334.33 Million | 214.5 Million | 200.86 Million |
| Operating Expenses | 243.37 Million | 268.57 Million | 321.15 Million | 236.98 Million | 181.13 Million | 172.63 Million |
| Selling, General and Administrative Expenses | 74.47 Million | 85.85 Million | 122.16 Million | 104.51 Million | 79 Million | 85.42 Million |
| Research and Development Expenses | 108.32 Million | 136.93 Million | 149.15 Million | 96.51 Million | 68.67 Million | 56.4 Million |
| Other Expenses | -13.2 Million | -3.45 Million | -3.29 Million | -765.11 Thousand | -794.07 Thousand | -981.49 Thousand |
| Cost and Expenses | 849.73 Million | 1.08 Billion | 1.8 Billion | 1.23 Billion | 850.29 Million | 746.86 Million |
| Operating Income | 34.52 Million | -41.11 Million | 85.19 Thousand | 72.16 Million | 37.64 Million | 26.5 Million |
| Interest Expense | 4.79 Million | 2.41 Million | 2.56 Million | 376.68 Thousand | 1.57 Million | 405.91 Thousand |
| Income Tax Expense | 1.91 Million | -6.43 Million | -2.93 Million | 4.03 Million | 6.95 Million | 6.46 Million |
| Earnings before Tax | 33.11 Million | -44.56 Million | -3.2 Million | 71.92 Million | 36.84 Million | 28.49 Million |
| Net Income | 34.36 Million | -32.29 Million | 8.86 Million | 70.16 Million | 31.06 Million | 24.01 Million |
| Earnings Per Share Basic | 0.16 | -0.15 | 0.04 | 0.37 | 0.16 | 0.13 |
| Earnings Per Share Diluted | 0.16 | -0.15 | 0.04 | 0.37 | 0.16 | 0.13 |
| Weighted Average Shares Outstanding | 214.7 Million | 214.7 Million | 214.29 Million | 189.62 Million | 188.8 Million | 184.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 214.7 Million | 214.7 Million | 214.29 Million | 189.62 Million | 188.8 Million | 184.73 Million |
| Gross Margin | 0.31 | 0.24 | 0.19 | 0.25 | 0.24 | 0.26 |
| EBIT Margin | 0.08 | 0.04 | 0.02 | 0.07 | 0.06 | 0.06 |
| Profit Margin | 0.04 | -0.03 | 0.00 | 0.05 | 0.04 | 0.03 |
| EBITDA | 74.37 Million | -5.2 Million | 23.55 Million | 90.38 Million | 56.63 Million | 51.01 Million |
| Earnings Before Tax Margin | 0.04 | -0.04 | 0.00 | 0.05 | 0.04 | 0.03 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 255.75 Million | 247.95 Million | 248.67 Million | 884.25 Million | 276.21 Million | 223.4 Million |
| Cost of Revenue | 166.01 Million | 161.27 Million | 158.01 Million | 610.68 Million | 188.53 Million | 146.5 Million |
| Gross Profit | 89.73 Million | 86.67 Million | 90.66 Million | 273.56 Million | 87.68 Million | 76.89 Million |
| Operating Expenses | 70.68 Million | 73.85 Million | 76.26 Million | 251.26 Million | 63.04 Million | 70.77 Million |
| Selling, General and Administrative Expenses | 47.64 Million | 49.05 Million | 47.22 Million | - | -10.16 Million | 68.11 Million |
| Research and Development Expenses | 23.04 Million | 22.55 Million | 27.63 Million | - | 28.46 Million | 26.59 Million |
| Other Expenses | - | -2.24 Million | -40.49 Thousand | -1.41 Million | -1.26 Million | 1.99 Million |
| Cost and Expenses | 236.7 Million | 235.13 Million | 234.27 Million | 861.95 Million | 251.57 Million | 217.28 Million |
| Operating Income | 19.04 Million | 12.82 Million | 13.9 Million | 34.52 Million | 17.75 Million | 7.45 Million |
| Interest Expense | 956.61 Thousand | 841.38 Thousand | 818.19 Thousand | 4.27 Million | 871.4 Thousand | 1.31 Million |
| Income Tax Expense | 215.11 Thousand | 321.14 Thousand | 1.13 Million | 1.91 Million | 411.83 Thousand | 768.66 Thousand |
| Earnings before Tax | 15.8 Million | 21.31 Million | 13.86 Million | 33.11 Million | 16.49 Million | 7.48 Million |
| Net Income | 15.67 Million | 21.18 Million | 13.66 Million | 34.36 Million | 19.18 Million | 6.54 Million |
| Earnings Per Share Basic | 0.07 | 0.10 | 0.06 | - | 0.09 | 0.03 |
| Earnings Per Share Diluted | 0.07 | 0.10 | 0.06 | - | 0.09 | 0.03 |
| Weighted Average Shares Outstanding | 216.58 Million | 213.79 Million | 227.75 Million | 214.7 Million | 214.7 Million | 214.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 216.58 Million | 213.79 Million | 227.75 Million | 214.7 Million | 214.7 Million | 214.7 Million |
| Gross Margin | 0.35 | 0.35 | 0.36 | 0.31 | 0.32 | 0.34 |
| EBIT Margin | 0.07 | 0.08 | 0.08 | - | 0.08 | 0.03 |
| Profit Margin | 0.06 | 0.09 | 0.05 | 0.04 | 0.07 | 0.03 |
| EBITDA | 16.76 Million | 20.38 Million | 19.2 Million | - | 22.76 Million | 6.08 Million |
| Earnings Before Tax Margin | 0.07 | 0.05 | 0.06 | 0.04 | 0.06 | 0.03 |
8395
BCNAF
TTGT
NXSCF
AYMSYNTEX
VAPIENTER